HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,107,414 | -0.0% | 731,602 | -3.7% | 0.09% | +2.3% |
| Q2 2023 | $65,136,021 | +18.6% | 759,592 | +14.5% | 0.09% | +15.8% |
| Q1 2023 | $54,926,266 | +33.9% | 663,664 | +28.6% | 0.08% | +38.2% |
| Q4 2022 | $41,026,145 | +81.6% | 516,224 | +72.1% | 0.06% | +66.7% |
| Q3 2022 | $22,592,000 | +11.4% | 300,014 | -2.9% | 0.03% | +17.9% |
| Q2 2022 | $20,286,000 | +6.4% | 309,020 | +1.8% | 0.03% | +21.7% |
| Q1 2022 | $19,069,000 | +19.7% | 303,525 | +1.0% | 0.02% | +21.1% |
| Q4 2021 | $15,926,000 | -25.8% | 300,588 | -1.5% | 0.02% | -29.6% |
| Q3 2021 | $21,476,000 | +5.4% | 305,209 | -0.7% | 0.03% | +3.8% |
| Q2 2021 | $20,383,000 | +1036.2% | 307,482 | +1437.0% | 0.03% | +1200.0% |
| Q2 2018 | $1,794,000 | – | 20,005 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |